| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082984 | Drug Discovery Today: Therapeutic Strategies | 2008 | 5 Pages |
Abstract
After decades of arduous work, considerable progress has been made in developing a new generation of treatments that may ease symptoms of Alzheimer’s disease and might even stop its progression. Several compounds are in mid- and late-stage clinical trials, and the first new drugs could be marketed in a few years. The drugs could be used to keep the disease in check, giving patients the prospect of living relatively normal lives.
Section editor:Leslie Iversen – Department of Pharmacology, University of Oxford, UK
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Beka Solomon,